CLS-CD-3575 Cells
USD$650.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | CLS-CD-3575 is a human cancer cell line included in curated cell line collections for oncological research. It is derived from a solid tumor of epithelial origin obtained from an adult patient and has been adapted to continuous in vitro culture. The cells grow adherently under standard culture conditions and exhibit morphology consistent with their tissue of origin, forming monolayers with epithelial-like characteristics. As with many established carcinoma cell lines, CLS-CD-3575 demonstrates stable proliferation and suitability for routine passaging. Molecularly, CLS-CD-3575 displays genomic alterations typical of malignant epithelial tumors, including chromosomal imbalances and deregulated signaling pathways associated with proliferation and survival. Depending on the specific tumor origin, expression of lineage-associated cytokeratins and tumor-related markers may be detected. Such features make the line suitable for studies of oncogenic signaling, cell cycle regulation, apoptosis, and drug response profiling in vitro. CLS-CD-3575 is used in experimental settings including cytotoxicity testing, molecular pathway analysis, and evaluation of targeted therapeutic strategies. Its reproducible growth characteristics and compatibility with standard biochemical, molecular biology, and imaging techniques make it a practical model for mechanistic cancer research and preclinical compound screening. |
|---|---|
| Organism | Mouse |
| Tissue | Kidney |
| Disease | Carcinoma |
| Synonyms | CLS-CD3575 |
Characteristics
| Age | Unspecified |
|---|---|
| Gender | Unspecified |
| Growth properties | Adherent |
Regulatory Data
| Citation | CLS-CD-3575 (Cytion catalog number 400146) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_5730 |
Biomolecular Data
| Tumorigenic | Yes, in syngeneic mice |
|---|
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 2 to 3 x 104 /cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Flask Coating | None |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|